Violation should not be counted in the total number of violations for the purpose of enhancing the CMP, and the proposed CMP would hamper the Respondent's business and indicate culpability where it is unproven. Respondent also contends that the proposed CMP is excessive because the evidence of record is insufficient to prove liability for any prior or current violations, the first Specifically, Respondent challenges the validity of the alleged prior violations and contends that the most recent alleged violation is inaccurate and did not occur because it has strictly-followed training and protocols for checking identification before tobacco sales. Respondent denies all allegations in the Complaint, raises several defenses to liability, and argues that the proposed CMP is too high and inappropriate. Specifically, CTP alleges that Respondent unlawfully sold covered tobacco products to a minor. ยงย 301 et seq., and its implementing regulations, 21 C.F.R. The Center for Tobacco Products (CTP) of the United States Food and Drug Administration (FDA) seeks a civil money penalty (CMP) of $570 against Respondent, Hazar Enterprises LLC d/b/a 7th Heaven, for committing three violations within a 24-month period of the Federal Food, Drug, and Cosmetic Act (Act), 21 U.S.C. About DAB has sub items, about About DAB.Medicare Appeals Council (Council) Decisions.DAB Administrative Law Judge (ALJ) Decisions.DAB Decisions has sub items, about DAB Decisions.
Alternative Dispute Resolution Services has sub items, about Alternative Dispute Resolution Services.Fully Integrated Duals Advantage (FIDA) Demonstration Project.Appeals to the Medicare Appeals Council (Council).
National Coverage Determination Complaints.